Stock 002581 SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Shandong Sinobioway Biomedicine Co., Ltd.

Equities

002581

CNE1000012Y5

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
11.41 CNY +0.62% Intraday chart for Shandong Sinobioway Biomedicine Co., Ltd. +0.71% -21.85%
Apr. 29 Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 29 Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Sinobioway Biomedicine Taps Builders for Planned Industrial Park
MT
Sinobioway Biomedicine Earmarks 1 Billion Yuan for Pharmaceutical Industrial Park
MT
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shenzhen Yilian Technology Limited Company and Shenzhen Jialian Private Equity Investment Fund Management Co., Ltd. won the auction to acquire 8.67% stake in Shandong Sinobioway Biomedicine Co., Ltd. from Beijing Sinobioway Group Co., Ltd. for CNY 77.85 million.
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Xiamen Hengxing Group Co., Ltd. acquired Shandong Sinobioway Biomedicine Co., Ltd. from Shenzhen Sandao Investment Management Enterprise (Limited Partnership) for CNY 200 million.
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002581 Stock
  4. News Shandong Sinobioway Biomedicine Co., Ltd.
  5. Highlights